admin@adna.org.au 03 8840 5072
IL17 and IL23 have largely superseded TNF inhibitors in psoriasis. However, they still play a significant role in rheumatology and gastroenterology.
Join Dr Andrew Östör (rheumatologist), Dr Emily Wright (gastroenterologist) and A/Prof Chris Baker(dermatologist) as they discuss where TNF inhibitors fit in the treatment options for psoriasis and explore TNF inhibitors and their competitors in inflammatory arthritis and inflammatory bowel disease (IBD).
Melanoma Institute Australia invites you to register for their free webinar for Skin Cancer GPs, General GPs and Nurses. Hosted by Skin Cancer GP, A/Prof Paul Fishburn, this engaging webinar will feature leading multidisciplinary experts sharing the latest updates on...
Plaque psoriasis clinical trial now open for recruitment! We are currently recruiting participants for a clinical trial on plaque psoriaisis, open to individuals aged 18 and older. This Phase 3 study is a randomised, double-blind, placebo and active comparator...
For this year's APNA Workforce Survey, we especially want to hear from nurses and midwives who have been underrepresented in previous surveys. For example, 12% of the primary health care nursing workforce identify as male, but just 5% of responses last year were from...
Are you a nurse or midwife interested in sharing your insights on drinking cultures within your professional community? Researchers from La Trobe University and Monash University want to hear from you! Researchers are conducting an online survey to explore the unique...
Conquering Skin Cancer is not your average documentary; it’s a compelling social impact film with a mission to prevent skin cancer. In a country where the “bronzed Aussie” image has led to more skin cancer deaths than road accident fatalities, the World Health...
WORLD PSORIASIS DAY 2024 29TH OCTOBER 2024 VISIT: https://psoriasisaustralia.org.au/
